REPL::Rights::Voluntary

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Security
IX BIOPHARMA LTD. - SG1BD9000009 - 42C

Announcement Details

Announcement Title
Outcome of Regulatory Review
Date &Time of Broadcast
22-Jun-2021 17:56:56
Status
Replacement
Corporate Action Reference
SG210608RHDIJTZ8
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Event Status
Pending Record Date Announcement
Underwritten
No
Shareholders' Approval Required?
No
Shareholders' Approval Obtained
No
Financial Year End
30/06/2021
Foreign Shareholder Eligibility
No
Attachment for Intent
iX - Launch of Rights Issue Announcement.pdf

Event Narrative

Narrative Type
Narrative Text
Additional TextPROPOSED RENOUNCEABLE NON-UNDERWRITTEN RIGHTS ISSUE OF UP TO 48,814,711 NEW ORDINARY SHARES IN THE CAPITAL OF IX BIOPHARMA LTD.

Dates

Record Date and Time
30/06/2021 17:00:00
Ex Date
29/06/2021
Attachment for Record Date
iX - Notice of Record Date Announcement 22 June 2021.pdf

Rights Details

Security Not Found?
No
Renounceable
Yes
Rights Security Distribution Ratio- Underlying
100
Rights Security Distribution Ratio- Rights Security
7

Option Exercise

Issue Price (Per Rights)
SGD 0.2
Disbursed Security
ISIN
Name
Security Type
Distribution Ratio- Rights
Distribution Ratio- Disbursed
SG1BD9000009IX BIOPHARMA LTD.Ordinary Share11

Renounceable Conditions

Allow Over Subscription
Yes

Attachments

iX - Launch of Rights Issue Announcement.pdf
iX - Receipt of LQN.pdf
iX - Notice of Record Date Announcement 22 June 2021.pdf
Total size =645K

Related Announcements

Related Announcements

30/06/2021 19:00:37
21/06/2021 19:16:23
08/06/2021 21:12:08